J E McLennan, K Nakano, H R Tyler, R S Schwab. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 1-PropanolDihydroxyphenylalanine/therapeutic useFemaleHandwritingHumansMaleNeurologic ManifestationsParkinson Disease/complicationsParkinson Disease/drug therapyPyrrolidines/therapeutic use
Substances: See more » PyrrolidinesDihydroxyphenylalanine1-Propanol
Year: 1972 PMID: 5010101 DOI: 10.1016/0022-510x(72)90002-0
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181